Food Oral Immunotherapy

Oral immunotherapy (OIT) is a treatment option for patients with food allergy in which the patient is given small quantities of the food every day, gradually building up tolerance to the offending food. Active clinical trials for oral immunotherapy have been ongoing for more than 20 years, and 10,000 patients have been desensitized to their respective food allergy triggers.

OIT is intended to reduce the severity of allergic reactions, including anaphylaxis, that could occur from accidental exposure to the food allergen. The triggering food should continue to be avoided outside of scheduled dosing, and the final dose is intended to be continued indefinitely. This therapy gradually decreases the sensitivity to small amounts of the allergen that may be hidden in foods and can decrease the frequency and severity of reactions to accidentally ingested allergen. OIT is not a cure, though it may be disease modifying.

Goals of Immunotherapy

Patients taking oral immunotherapy report higher quality-of-life scores related to their food allergy. Having food allergies places enormous burden on patients and families, and oral immunotherapy can give patients greater control over their food allergy. After completing the build-up phase, most patients can consume foods which “may contain” the trigger. For those who are highly allergic, the goal of therapy is to become bite tolerant” meaning no reactions to an accidental ingestion of a small amount of the food. After 2 years of therapy, we may discuss an oral challenge to determine the safety of consuming the food without restrictions.

Safety/Risks

Oral immunotherapy can trigger a severe allergic reaction/anaphylaxis which can be life-threatening. The most common side effects were abdominal pain, vomiting, throat irritation/tightness, cough, wheezing, shortness of breath, nasal symptoms including runny nose/sneezing, and itchy skin/mouth/ears and hives. OIT is NOT recommended for patients with uncontrolled asthma, history of mastocytosis or eosinophilic esophagitis, or who are unable to receive or self-administer injectable or nasal epinephrine.

Allergic reactions are more likely in the presence of cofactors such as exercise, illness/active infection, fasting, hot water exposure, sleep deprivation, menstruation, and recent NSAID use. Patients should adjust the dose at home according to the doctor’s recommendations in the presence of these cofactors. Severe reactions which occur during treatment will need to be treated with injectable epinephrine, as well as evaluation at the nearest emergency room or urgent care clinic.

Oral immunotherapy can also cause inflammation of the esophagus (eosinophilic esophagits) and cannot be given to a patient with preexisting eosinophilic esophagitis or other eosinophilic gastrointestinal disease. The symptoms of this condition include trouble swallowing, food becoming stuck in the throat or chest, abdominal pain, and vomiting.

OIT vs. Sublingual Immunotherapy

There is a higher risk of side effects, anaphylaxis/allergic reactions, food aversions, and dose-related anxiety for patients being treated with OIT compared to sublingual immunotherapy (SLIT). There are more office visits for OIT (12+ compared to 4 with SLIT), but each visit is shorter, requiring 1 hour of monitoring vs. 2-3 hours. SLIT does not require activity restrictions and there have been no reported cases of eosinophilic esophagitis. OIT offers the patient the ability to consume small amounts of the actual food, and may increase the likelihood of achieving tolerance to the allergenic food and possibly remission of food allergy.

The differences are summarized in the following table:.

Interested in Oral Immunotherapy?

Dr. Joshua Phillips currently offers oral immunotherapy to peanuts and other foods on a case by case basis in the Jackson office. Call for an appointment to discuss the risks and benefits of this treatment.